This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. (MRNA) slipped 3.04% to $125.76 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.79% to 11,220.19 and Dow Jones Industrial Average falling 1.70% to 30,183.78. Moderna Inc. closed $332.74 short of its 52-week high ($458.50), which the company reached on September 23rd.
The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. (ABBV) fell 1.03% to $140.31, Amgen Inc. (AMGN) fell 1.43% to $224.46, and AstraZeneca PLC ADR (AZN.LN) fell 1.67% to $56.44. Trading volume (3.8 M) remained 1.0 million below its 50-day average volume of 4.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 21, 2022.
(END) Dow Jones Newswires
September 21, 2022 16:32 ET (20:32 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.